BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21722606)

  • 1. Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
    Bitencourt Dias C; Pinheiro CC; Malafronte P; Titan S; Alves de Brito G; Gera Abrão J; Dos Santos Silva V; Toledo Barros R; Woronik V
    Clin Nephrol; 2011 Jul; 76(1):57-63. PubMed ID: 21722606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression.
    Chan TM; Li FK; Hao WK; Chan KW; Lui SL; Tang S; Lai KN
    Lupus; 1999; 8(7):545-51. PubMed ID: 10483033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
    Hu WX; Chen YH; Bao H; Liu ZZ; Wang SF; Zhang HT; Liu ZH
    Lupus; 2015 Sep; 24(10):1067-75. PubMed ID: 25819933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
    Zhang M; Qi C; Zha Y; Chen J; Luo P; Wang L; Sun Z; Wan J; Xing C; Wang S; Jiang G; Sun M; Chen Q; Chen J; Li D; Guan T; Ni Z
    Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population.
    Mejía-Vilet JM; Córdova-Sánchez BM; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Sep; 35(9):2219-27. PubMed ID: 27475791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
    Fischer-Betz R; Chehab G; Sander O; Vordenbäumen S; Voiculescu A; Brinks R; Schneider M
    J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
    Mehra S; Usdadiya JB; Jain VK; Misra DP; Negi VS
    Rheumatol Int; 2018 Apr; 38(4):557-568. PubMed ID: 29450636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
    Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
    Matsumoto Y; Shimada Y; Nojima Y; Moriki T
    Ren Fail; 2013 Aug; 35(7):936-41. PubMed ID: 23815417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
    Chan TM; Li FK; Wong RW; Wong KL; Chan KW; Cheng IK
    Nephron; 1995; 71(3):321-7. PubMed ID: 8569982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
    Kasitanon N; Petri M; Haas M; Magder LS; Fine DM
    Lupus; 2008 Jan; 17(1):40-5. PubMed ID: 18089682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of refractory lupus nephritis with a protocol including rituximab.
    Fra GP; Avanzi GC; Bartoli E
    Lupus; 2003; 12(10):783-7. PubMed ID: 14596429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone.
    Bruns FJ; Adler S; Fraley DS; Segel DP
    Ann Intern Med; 1991 May; 114(9):725-30. PubMed ID: 2012353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
    Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
    Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.